Author

Roberto Iacovelli

Institution: Agostino Gemelli University Polyclinic

Observed institution: Agostino Gemelli University Polyclinic

OpenAlex ID: A5159737949

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial

2026 · Robert J Motzer, Ray McDermott, et al. · The Lancet · 7

Works count: 2

Citation count: 14

H-index: 2

I10-index: